Kamada Ltd. (KMDA) Posts Robust 2025 Financial Outlook with Revenue and EBITDA Growth Expectations

Monday, Nov 10, 2025 5:40 pm ET1min read

Kamada Ltd (KMDA) reaffirms 2025 financial outlook with total revenues projected between $178 million and $182 million, and adjusted EBITDA between $40 million and $44 million, indicating significant revenue and EBITDA growth. The company operates in the healthcare sector, focusing on plasma-derived protein therapeutics, with a robust product portfolio and strong financial health. Favorable valuation ratios and positive analyst sentiment further support Kamada's growth trajectory.

Kamada Ltd. (KMDA) Posts Robust 2025 Financial Outlook with Revenue and EBITDA Growth Expectations

Comments



Add a public comment...
No comments

No comments yet